Article Details

Bioxyne granted Australia's first GMP licence for Psilocybin and MDMA manufacturing

Retrieved on: 2024-02-05 01:05:45

Tags for this article:

Click the tags to see associated articles and topics

Bioxyne granted Australia's first GMP licence for Psilocybin and MDMA manufacturing. View article details on HISWAI: https://www.australianmanufacturing.com.au/bioxyne-granted-australias-first-gmp-licence-for-psilocybin-and-mdma-manufacturing/

Summary

Bioxyne Limited's subsidiary, Breathe Life Sciences, is the first in Australia to receive a GMP license for producing medical cannabis, MDMA, and psilocybin, targeting mental health treatments. This move facilitates innovative therapies and positions Bioxyne as a leader in alternative medicine manufacturing.

Article found on: www.australianmanufacturing.com.au

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up